The partnership will accelerate AI-powered medical imaging across major overseas channels
Lunit, a global provider of AI-powered cancer solutions, has signed a global distribution agreement with CARPL.ai, an end-to-end healthcare technology platform that enables the development, validation, and deployment of AI solutions across clinical workflows.
Under the agreement, Lunit will deliver Lunit INSIGHT CXR, an AI solution for chest x-ray image analysis, and Lunit INSIGHT MMG, an AI solution for mammography analysis, through CARPL’s platform across five countries: US, Australia, Brazil, India and Singapore.
CARPL is an end-to-end technology platform for the development, validation, and deployment of medical imaging AI applications in clinical workflows. Used by some of the world’s top AI researchers and health systems, it provides a unique platform connecting picture archiving and communication systems (PACS) in clinical settings with third-party AI applications.
Through CARPL’s interface, healthcare providers can seamlessly access Lunit’s AI solution suite for radiology, thereby improving access, affordability, and quality of medical care globally.
“We are delighted to team up with CARPL, which enables Lunit’s products to be more easily accessed by customers across major overseas markets,” said Brandon Suh, CEO, Lunit. “Through this partnership, Lunit will continue to actively expand our sales network in the global market.”
“CARPL.ai drives the adoption of radiology AI solutions into clinical workflows. We seek to improve patient outcomes by empowering healthcare service providers with access to leading AI solutions and the ability to discover, explore, validate, and confidently deploy healthcare AI in their clinical environment,” said Dr Vidur Mahajan, Chief Executive Officer of CARPL.ai. “We are excited to partner with Lunit to offer our customers access to leading chest digital radiography and mammography AI solutions through Lunit INSIGHT CXR and Lunit INSIGHT MMG.”
